Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Interest Expenses (2017 - 2025)

PAVmed has reported Interest Expenses over the past 5 years, most recently at $5000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 28.57% year-over-year to $5000.0; the TTM value through Dec 2025 reached $21000.0, down 38.24%, while the annual FY2025 figure was $21000.0, 53.33% down from the prior year.
  • Interest Expenses for Q4 2025 was $5000.0 at PAVmed, down from $8000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $525000.0 in Q3 2022 and troughed at $4000.0 in Q1 2021.
  • A 5-year average of $128533.3 and a median of $16000.0 in 2024 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: tumbled 95.18% in 2024 and later dropped 28.57% in 2025.
  • Year by year, Interest Expenses stood at $4000.0 in 2021, then soared by 5700.0% to $232000.0 in 2022, then plummeted by 91.81% to $19000.0 in 2023, then tumbled by 63.16% to $7000.0 in 2024, then dropped by 28.57% to $5000.0 in 2025.
  • Business Quant data shows Interest Expenses for PAVM at $5000.0 in Q4 2025, $8000.0 in Q3 2025, and $4000.0 in Q2 2025.